Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3β

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Zhou, Mingjie ^a,b   Ren, Huanhuan ^c   Han, Jichun ^c   Wang, Wenjuan ^c   Zheng, Qiusheng ^c,d   Wang, Dong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d SHIHEZI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; BLOOD PRESSURE; CELL DEATH; CELLS; CYTOLOGY; ELECTROPHORESIS; ENZYMES; OXYGEN; PLANTS (BOTANY); RATS;

ANTI-OXIDANT ACTIVITIES; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOGEN SYNTHASE KINASE-3; LACTATE DEHYDROGENASE; MYOCARDIAL INFARCT SIZES; SUPEROXIDE DISMUTASES; TUMOR NECROSIS FACTOR ALPHA; WESTERN-BLOT ANALYSIS;

FLAVONOIDS;

3,4 METHYLENEDIOXYAMPHETAMINE; CASPASE 3; CREATINE KINASE; CYTOCHROME; CYTOCHROME C; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOGEN SYNTHASE KINASE 3BETA; KAEMPFEROL; LACTATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, RAT; KAEMPFEROL DERIVATIVE; PROTECTIVE AGENT; THIADIAZOLE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; STAINING; TUNEL ASSAY; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CYTOLOGY; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; CASPASE 3; CYTOCHROMES C; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HEART; IN VITRO TECHNIQUES; KAEMPFEROLS; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PHOSPHORYLATION; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIADIAZOLES;

EID: 84938635678     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/481405     Document Type: Article

References (34)

1. Q. Fan, L. Chen, S. Cheng, et al., "Aging aggravates nitratemediated ROS/RNS changes, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 376515, 7 pages, 2014.
2. M. Juhaszova, D. B. Zorov, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott, "Role of glycogen synthase kinase-3β in cardioprotection, " Circulation Research, vol. 104, no. 11, pp. 1240-1252, 2009.
3. R. B. Jennings, "Historical perspective on the pathology of myocardial ischemia/reperfusion injury, " Circulation Research, vol. 113, no. 4, pp. 428-438, 2013.
4. K. Przyklenk, Y. Dong, V. V. Undyala, and P. Whittaker, "Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges, " Cardiovascular Research, vol. 94, no. 2, pp. 197-205, 2012.
5. H. Liu, J. Wang, W. Zhou, Y. Wang, and L. Yang, "Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice, " Journal of Ethnopharmacology, vol. 146, no. 3, pp. 773-793, 2013.
6. A. Ali, K. P. Hoeflich, and J. R. Woodgett, "Glycogen synthase kinase-3: properties, functions, and regulation, " Chemical Reviews, vol. 101, no. 8, pp. 2527-2540, 2001.
7. S. H. Ramirez, S. Fan, M. Zhang, et al., "Inhibition of glycogen synthase kinase 3β (GSK3β) decreases inflammatory responses in brain endothelial cells, " The American Journal of Pathology, vol. 176, no. 2, pp. 881-892, 2010.
8. S. Cuzzocrea, C. Crisafulli, E. Mazzon, et al., "Inhibition of glycogen synthase kinase-3β attenuates the development of carrageenan-induced lung injury in mice, " British Journal of Pharmacology, vol. 149, no. 6, pp. 687-702, 2006.
9. P. H. Sugden, S. J. Fuller, S. C. Weiss, and A. Clerk, "Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis, " British Journal of Pharmacology, vol. 153, no. S1, pp. S137-S153, 2008.
10. A. Mora, K. Sakamoto, E. J. McManus, and D. R. Alessi, "Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart, " FEBS Letters, vol. 579, no. 17, pp. 3632-3638, 2005.
11. M. Juhaszova, D. B. Zorov, S.-H. Kim, et al., "Glycogen synthase kinase-3β mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore, " Journal of Clinical Investigation, vol. 113, no. 11, pp. 1535-1549, 2004.
12. M. Nishihara, T. Miura, T. Miki, et al., "Modulation of the mitochondrial permeability transition pore complex in GSK-3β-mediated myocardial protection, " Journal of Molecular and Cellular Cardiology, vol. 43, no. 5, pp. 564-570, 2007.
13. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang, "Flavonoids: promising anticancer agents, " Medicinal Research Reviews, vol. 23, no. 4, pp. 519-534, 2003.
14. M. López-Lázaro, "Distribution and biological activities of the flavonoid luteolin, "Mini-Reviews inMedicinal Chemistry, vol. 9, no. 1, pp. 31-59, 2009.
15. A. R. Verma, M. Vijayakumar, C. S. Mathela, and C. V. Rao, "In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves, " Food and Chemical Toxicology, vol. 47, no. 9, pp. 2196-2201, 2009.
16. M. J. Park, E. K. Lee, H.-S. Heo, et al., "The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinase pathways, " Journal of Medicinal Food, vol. 12, no. 2, pp. 351-358, 2009.
17. M. A. Gates, S. S. Tworoger, J. L. Hecht, I. de Vivo, B. Rosner, and S. E. Hankinson, "A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer, " International Journal of Cancer, vol. 121, no. 10, pp. 2225-2232, 2007.
18. J. L. Zweier, J. Fertmann, and G. Wei, "Nitric oxide and peroxynitrite in postischemic myocardium, " Antioxidants & Redox Signaling, vol. 3, no. 1, pp. 11-22, 2001.
19. Y. Wang, P. Xu, H. Liu, Y. Zhou, and X. Cao, "The protection of salidroside of the heart against acute exhaustive injury and molecular mechanism in rat, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 507832, 8 pages, 2013.
20. H. Pang, B. Han, T. Yu, and Z. Peng, "The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy, " PLoS ONE, vol. 9, no. 3, Article ID e92216, 2014.
21. Z. Xia, Y. Chen, Q. Fan, and M. Xue, "Oxidative stressmediated reperfusion injury: mechanism and therapies, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 373081, 2 pages, 2014.
22. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
23. W. Dröge, "Free radicals in the physiological control of cell function, " Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
24. Y. Wang, X. Li, X. Wang, et al., "Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway, " PLoS ONE, vol. 8, no. 8, Article ID e70956, 2013.
25. B. S. Cain, D. R. Meldrum, C. A. Dinarello, et al., " Tumor necrosis factor-α and interleukin-1β synergistically depress humanmyocardial function, " Critical CareMedicine, vol. 27, no. 7, pp. 1309-1318, 1999.
26. M. Sugano, T. Hata, K. Tsuchida, et al., "Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats, " Molecular and Cellular Biochemistry, vol. 266, no. 1-2, pp. 127-132, 2004.
27. P. Korge, P. Ping, and J. N. Weiss, "Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide, " Circulation Research, vol. 103, no. 8, pp. 873-880, 2008.
28. T. Miura and T. Miki, "GSK-3β, a therapeutic target for cardiomyocyte protection, " Circulation Journal, vol. 73, no. 7, pp. 1184-1192, 2009.
29. A. Wyllie, "Clues in the p53 murder mystery, " Nature, vol. 389, no. 6648, pp. 237-238, 1997.
30. P. Korge, H. M. Honda, and J. N. Weiss, "Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 3312-3317, 2002.
31. V. Borutaite, A. Jekabsone, R. Morkuniene, and G. C. Brown, "Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia, " Journal of Molecular and Cellular Cardiology, vol. 35, no. 4, pp. 357-366, 2003.
32. S.-S. Park, H. Zhao, Y. Jang, R. A. Mueller, and Z. Xu, " N6-(3-Iodobenzyl)-adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3β, " Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 1, pp. 124-131, 2006.
33. J. Feng, E. Lucchinetti, P. Ahuja, T. Pasch, J.-C. Perriard, and M. Zaugg, "Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3β, " Anesthesiology, vol. 103, no. 5, pp. 987-995, 2005.
34. H. K. Gao, Z. Yin, N. Zhou, X. Y. Feng, F. Gao, and H. C. Wang, "Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis, " Journal of Cardiovascular Pharmacology, vol. 52, no. 3, pp. 286-292, 2008.